mitomycin has been researched along with Adenocarcinoma, Clear Cell in 8 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Adenocarcinoma, Clear Cell: An adenocarcinoma characterized by the presence of varying combinations of clear and hobnail-shaped tumor cells. There are three predominant patterns described as tubulocystic, solid, and papillary. These tumors, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. (From Holland et al., Cancer Medicine, 3d ed)
Excerpt | Relevance | Reference |
---|---|---|
"Among advanced ovarian cancer, OCCA has worse prognosis compared with serous cystadenocarcinoma because of its poor sensitivity to CDDP-based chemotherapy (CTX)." | 2.68 | [Successful treatment of clear cell adenocarcinoma of the ovary (OCCA) with a combination of CPT-11 and mitomycin C]. ( Hasumi, K; Shimizu, Y; Umezawa, S, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Seki, H | 1 |
Takada, T | 1 |
Sodemoto, T | 1 |
Hoshino, H | 1 |
Saitoh, K | 1 |
Uekusa, T | 1 |
Nishino, K | 1 |
Aoki, Y | 1 |
Amikura, T | 1 |
Obata, H | 1 |
Sekine, M | 1 |
Yahata, T | 1 |
Fujita, K | 1 |
Tanaka, K | 1 |
Shimizu, Y | 3 |
Umezawa, S | 3 |
Hasumi, K | 3 |
Rakovitch, E | 1 |
Fyles, AW | 1 |
Pintilie, M | 1 |
Leung, PM | 1 |
Tanaka, T | 1 |
Umesaki, N | 1 |
Ogita, S | 1 |
Itamochi, H | 1 |
Kigawa, J | 1 |
Sultana, H | 1 |
Iba, T | 1 |
Akeshima, R | 1 |
Kamazawa, S | 1 |
Kanamori, Y | 1 |
Terakawa, N | 1 |
3 trials available for mitomycin and Adenocarcinoma, Clear Cell
Article | Year |
---|---|
Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptotheci | 2005 |
[Successful treatment of clear cell adenocarcinoma of the ovary (OCCA) with a combination of CPT-11 and mitomycin C].
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptotheci | 1996 |
A phase II study of combined CPT-11 and mitomycin-C in platinum refractory clear cell and mucinous ovarian carcinoma.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Antineoplastic Agents, Phytogenic; Antineoplas | 1998 |
5 other studies available for mitomycin and Adenocarcinoma, Clear Cell
Article | Year |
---|---|
A young woman with clear cell adenocarcinoma of the uterine cervix.
Topics: Adenocarcinoma, Clear Cell; Adolescent; Age of Onset; Antineoplastic Combined Chemotherapy Protocols | 2003 |
[The results of chemosensitivity test for clear cell adenocarcinoma of the ovary].
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; | 1996 |
Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplas | 1997 |
Camptothecin and mitomycin combination chemotherapy on ovarian clear cell carcinoma with multiple systemic metastases.
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Admin | 2000 |
Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.
Topics: Adenocarcinoma, Clear Cell; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agent | 2002 |